Analyst Leland Gershell works at OPPENHEIMER and is focused on the Healthcare sector with 216 price targets and ratings documented since 2018 spanning on 27 stocks. Analyst's average stock valuation to be materialised ratio is 31.91% with an average time for price targets to be met of 83.95 days.
Most recent stock forecast was given on BMRN, BioMarin Pharmaceutical Inc at 31-Oct-2022.
Leland Gershell best performing recommendations are on AMRN (AMARIN CORPORATION PLC).
The best stock recommendation documented was for AMRN (AMARIN CORPORATION PLC) at 2/26/2020. The price target of $12 was fulfilled within 15 days with a profit of $4.27 (26.24%) receiving and performance score of 17.5.
Average potential price target upside
